U.S. Pharma Stock News

Trex Company (TREX) opened 2026 with Q1 revenue of US$343.4 million and basic EPS of US$0.58, compared with US$340.0 million of revenue and EPS of US$0.56 in the same quarter a year earlier. Trailing 12 month EPS stood at US$1.80 on revenue of US$1.18 billion. Over recent quarters the company has reported revenue in a range between US$161.1 million and US$387.8 million and quarterly EPS between roughly US$0.02 and US$0.71. This gives investors a clearer view of how current Q1 levels compare...

Centuri Holdings (CTRI) opened Q1 2026 with revenue of US$723.2 million and a net loss of US$9.5 million, or basic EPS of US$0.09. The trailing twelve months show revenue of about US$3.2 billion and net income of US$30.8 million, or EPS of US$0.33. Over recent quarters, the company has reported revenue moving from US$550.1 million in Q1 2025 to US$723.2 million in Q1 2026, with quarterly EPS ranging from a loss of US$0.20 to a profit of US$0.32. For investors, the key question now is how...

Amphastar Pharmaceuticals, Inc. reported its first-quarter 2026 results on May 7, 2026, with sales of US$171.17 million and net income of US$6.42 million, compared with US$170.53 million and US$25.29 million a year earlier. The sharp fall in net income and earnings per share, despite essentially flat sales, points to pressure on Amphastar’s profitability and cost structure. With Amphastar’s net income falling year over year despite stable sales, we’ll now examine how this affects the...

Energy Recovery (ERII) opened Q1 2026 with revenue of US$9.7 million and a basic EPS loss of US$0.23, alongside net income excluding extra items of a US$12.3 million loss, setting a clear reset in earnings season tone for investors. Over the past year, the company has seen trailing twelve month revenue move between US$144.9 million and US$136.6 million, with basic EPS on this basis ranging from US$0.40 to US$0.39. This gives a fuller view of how quarterly swings sit against the broader...

Flutter Entertainment (NYSE:FLUT) opened 2026 with Q1 revenue of $4.3 billion and basic EPS of $1.24, while trailing 12 month revenue sat at $17.0 billion against a basic EPS of $2.12 loss, so the latest quarter lands against a still loss making year in aggregate. Over the past year, the company has seen revenue move from $14.3 billion on a trailing 12 month basis in Q1 2025 to $17.0 billion in Q1 2026, with quarterly EPS swinging between a $3.92 loss in Q3 2025 and $1.24 in the most recent...

Aclaris Therapeutics (ACRS) opened Q1 2026 with revenue of about US$2.0 million and a basic EPS loss of roughly US$0.15 per share. Trailing twelve month figures show revenue of US$8.4 million and a cumulative basic EPS loss of around US$0.56. Over recent quarters, revenue has moved between US$1.3 million and US$3.3 million, while quarterly basic EPS losses have sat in a range of roughly US$0.12 to US$0.16 per share, keeping the focus squarely on how much further margins can be tightened to...

IonQ (IONQ) opened Q1 2026 with total revenue of US$64.7 million and basic EPS of US$2.24, supported by trailing twelve month revenue of US$187.1 million and basic EPS of US$1.05. Over the past year, the company has seen quarterly revenue move from US$11.7 million in Q4 2024 to US$7.6 million in Q1 2025, then to US$20.7 million, US$39.9 million, US$61.9 million, and now US$64.7 million. Over the same period, quarterly basic EPS shifted from a loss of US$0.93 to US$0.14, US$0.70, US$3.58,...

Americold Realty Trust (COLD) has opened Q1 2026 with total revenue of US$629.9 million and basic EPS of a US$0.05 loss, setting a clear marker for how its cold storage portfolio is currently translating into the income statement. Over recent periods, revenue has ranged between US$627.6 million and US$665.8 million per quarter, while basic EPS has moved between a US$0.31 loss and a small profit of roughly US$0.01. This gives investors a focused view of how top line scale is feeding through to...

Alpha Teknova (TKNO) opened Q1 2026 with revenue of US$11.1 million and a loss of US$4.6 million, translating to basic EPS of US$0.08 loss as the company continued to invest ahead of profitability. Over recent quarters, revenue has moved from US$9.8 million in Q1 2025 and US$9.3 million in Q4 2024 to the latest US$11.1 million. Basic EPS has stayed in a tight band around a US$0.08 to US$0.11 loss, indicating that the focus remains on scaling revenue rather than delivering positive earnings...

Somnigroup International (SGI) opened 2026 with Q1 revenue of US$1.8 billion and basic EPS of US$0.50, setting the tone for how investors will read the rest of this year’s earnings story. Over the past year, the company has seen trailing twelve month revenue move from US$4.9 billion to US$7.7 billion, while trailing EPS shifted from US$2.21 to US$2.48. This gives you a clear view of how top line and per share results have tracked ahead of this quarter. With net margin over the last 12 months...

Arcutis Biotherapeutics (ARQT) opened Q1 2026 with total revenue of US$105.4 million, basic EPS of a US$0.09 loss, and a net income loss of US$11.3 million, while its trailing twelve month revenue stood at US$415.6 million and basic EPS at a US$0.02 loss. Over recent quarters, the company reported revenue moving from US$71.4 million in Q4 2024 to US$129.5 million in Q4 2025, with quarterly basic EPS shifting between a loss of US$0.20 in Q1 2025 and a profit of US$0.14 in Q4 2025. For...

Hudson Pacific Properties (HPP) opened 2026 with Q1 revenue of US$181.9 million and basic EPS of US$0.82 loss per share, while trailing twelve month revenue stood at US$814.4 million against a TTM basic EPS of US$9.88 loss per share. Over recent quarters, revenue has moved between US$185.9 million and US$258.2 million while EPS ranged from a US$2.12 loss per share to a US$8.28 loss per share, giving investors a clear view of a business that is still working through weak margins and a long...

Xometry Q1 2026 Earnings Snapshot Xometry (XMTR) just posted Q1 2026 results with revenue of US$205.1 million, a basic EPS loss of US$0.05 and net income excluding extra items of a US$5.3 million loss, setting the stage for another quarter in which growth and profitability remain in focus. Over the past year, revenue has moved from US$151.0 million in Q1 2025 to US$205.1 million in Q1 2026, while basic EPS losses shifted from US$0.30 to US$0.05, giving investors a clearer read on how quickly...

Black Hills (BKH) opened 2026 with Q1 revenue of US$780.7 million and basic EPS of US$1.74, alongside trailing 12 month EPS of US$3.90 on revenue of US$2.3 billion. This gives investors a clear read on both the latest quarter and the broader earnings run rate. Over the past year, the company has seen quarterly revenue range from US$430.2 million to US$805.2 million, while basic EPS moved between US$0.34 and US$1.88, setting a wide but well defined band for how the business is currently...

Castle Biosciences (CSTL) opened Q1 2026 with revenue of US$83.7 million and a basic EPS loss of US$0.49, as net income excluding extra items came in at a loss of US$14.5 million. Over recent quarters, the company has seen revenue move between US$83.0 million and US$88.0 million while basic EPS has ranged from a loss of US$0.90 to a profit of US$0.16. This gives investors a clear view of how margins have been stretching and compressing as the business scales. See our full analysis for Castle...

Sempra (SRE) has opened 2026 with Q1 revenue of US$3.7b and basic EPS of US$1.59, putting fresh numbers on the table for investors tracking the stock at US$91.57. Over recent quarters, the company has seen quarterly revenue move between US$3.0b and US$3.8b, while basic EPS has ranged from about US$0.12 to US$1.59. This has taken place against a backdrop of earnings growth forecasts at roughly 15% per year and recent margin compression from 21.9% to 14.2%. The latest print therefore focuses...

PTC (PTC) has put up a punchy Q2 2026 print, with revenue of US$774.3 million and basic EPS of US$5.00 anchored by net income of US$590.7 million. This comes against a backdrop of trailing 12 month revenue of about US$3.0 billion and basic EPS of US$10.45. Over recent quarters the company has seen revenue move from US$636.4 million in Q2 2025 to US$774.3 million in Q2 2026, while basic EPS has shifted from US$1.35 to US$5.00 over the same period. This sets the scene for investors to focus on...

APA (APA) opened Q1 2026 with total revenue of US$2.3 billion and basic EPS of US$1.26, supported by trailing 12 month revenue of US$8.4 billion and EPS of US$4.30 that coincide with net margin improving to 18.3% from 10%. The company has seen trailing 12 month net income move from US$804 million a year ago to US$1.5 billion, while earnings grew 50.4% over that period. For investors weighing a roughly 2.8% dividend yield, a low P/E multiple and richer margins against forecasts for modest...

OraSure Technologies (OSUR) opened 2026 with Q1 revenue of US$27.9 million and a basic EPS loss of US$0.32, alongside a trailing twelve month revenue base of US$113.0 million and a basic EPS loss of US$1.04. Over recent quarters the company has seen revenue move from US$29.9 million in Q1 2025 and US$37.4 million in Q4 2024 to the latest US$27.9 million print. Quarterly basic EPS losses shifted from US$0.21 and US$0.14 in those periods to US$0.32, so investors are likely to focus on how...

Brighthouse Financial (BHF) opened 2026 with Q1 revenue of US$1.5b and a basic EPS loss of US$13.72, alongside net income excluding extra items of a US$792m loss. On a trailing 12 month basis, revenue stood at US$6.1b with a basic EPS loss of US$2.92 and a US$167m net loss. Over recent quarters the company has seen revenue move from US$2.4b in Q1 2025 to US$1.9b in Q4 2025 and US$1.5b in Q1 2026. Basic EPS has ranged from a loss of US$5.05 in Q1 2025 to a profit of US$10.80 in Q4 2024 before...

ATN International (ATNI) opened 2026 with Q1 revenue of US$182.2 million and a basic EPS loss of US$0.18, while trailing 12 month revenue stood at US$730.9 million against a net loss of US$14.9 million. Over recent quarters, revenue has moved in a tight band between US$179.3 million and US$184.2 million. During the same period, basic EPS has swung from a profit of US$0.18 in Q3 2025 to losses of US$0.56 in Q2 2025 and US$0.32 in Q4 2025. This sets up a quarter where investors are focused less...

M&T Bank is actively assessing targeted acquisitions within its 13 state footprint to increase regional scale. The company is focusing on adding density in existing markets rather than pursuing a national expansion strategy. This comes as regulators appear more open to bank mergers, creating a more supportive backdrop for deals. M&T Bank (NYSE:MTB) is sharpening its focus on regional growth, with management exploring acquisitions that fit within its existing footprint instead of chasing...

FY 2026 earnings snapshot and how the stories stack up NVE (NVEC) has just wrapped up FY 2026 with fourth quarter revenue of US$7.7 million and basic EPS of US$1.02, set against trailing twelve month revenue of US$26.3 million and EPS of US$3.14 as the stock trades at US$88.59. Over recent quarters the company has seen revenue range from US$6.1 million to US$7.7 million and quarterly EPS move between US$0.68 and US$1.02. This gives investors a clearer read on how the topline and per share...

Mirum Pharmaceuticals (MIRM) just posted Q1 2026 results with revenue of US$159.9 million, a basic EPS loss of US$13.43 and net income loss excluding extra items of US$790.2 million. The company has reported quarterly revenue of US$99.4 million in Q4 2024, US$111.6 million in Q1 2025, US$127.8 million in Q2 2025, US$133.0 million in Q3 2025 and US$148.9 million in Q4 2025, while EPS over those periods ranged between a loss of US$0.50 and a profit of US$0.06. For investors, a key focus this...